Help
Subscribe


GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy

 23 January 2018

Advanced search
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

Preoperative predictors of survival after resection of small HCC are identified

Patients with small hepatocellular cancers, who will derive the least benefit from resection, can be identified before surgery, using a score based on tumor grade and severity of underlying liver disease, claim researchers from the USA, Japan, and France.

News image

fiogf49gjkf04

The team determined preoperative predictors of survival that can guide the choice of treatment for patients with small hepatocellular cancers (HCCs).

The findings of the trial were published in the May issue of the Annals of Surgery.

Currently, the treatment of patients with small (≤ 5 cm in diameter) HCCs is controversial.

A cohort of 249 patients (69 women, median age 62 years) who underwent resection with curative intent for small HCC was identified from a multiinstitutional database.

For each patient, the clinical data and pathology slides were reviewed.

A total of 6 clinical factors (age, gender, preoperative alpha-fetoprotein level, hepatitis serology, number of tumors [single vs multiple], and Child-Pugh score) and 3 pathologic factors (hepatitis activity score, fibrosis score, and Edmondson-Steiner tumor grade) were assessed before surgery.

All of these factors were correlated with survival.

The researchers found that median overall survival for the entire cohort was 4.2 years.

Predictors of survival after resection:
- Fibrosis score
- Edmondson-Steiner grade
- Child-Pugh score
Annals of Surgery
The estimated overall 5- and 8-year survival rates were 41% and 20%, respectively.

Multivariate Cox analysis indicated that fibrosis score, Edmondson-Steiner grade, and Child-Pugh score were simultaneously significant predictors of survival after resection.

The team derived a prognostic scoring system based on these covariates and applied it to the entire cohort.

Patients lacking all 3 risk factors were assigned a score of 1, patients with 1 risk factor were assigned a score of 2, and patients with 2 or 3 risk factors were assigned a score of 3.

Pairwise log-rank tests indicated significant differences in survival between scores 1 and 2, scores 2 and 3, and scores 1 and 3.

A subset of 98 patients, with positive hepatitis C serology, was analyzed separately. This scoring system was still found to retain its prognostic significance.

Dr Jeffrey D. Wayne, of the University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA, said on behalf of his colleagues, "Patients with small HCCs, who will derive the least benefit from resection, can be identified before surgery.

"This can be done using a score based on tumor grade and the severity of underlying liver disease."

"In these patients, transplantation and/or ablation should be considered as possible alternative therapies,"

Ann Surg 2002; 235(5): 722-31
02 May 2002

Go to top of page Email this page Email this page to a colleague

 23 January 2018 
Atrophic gastritis after H. pylori eradication
 23 January 2018 
Ectopic pregnancy in women with IBD
 23 January 2018 
Celiac disease in IBS in the USA
 22 January 2018 
Improving symptoms in GERD
 22 January 2018 
Costs of biologic therapies for IBD in the USA
 22 January 2018 
Western vs Asian guidelines for colon cancer management
 19 January 2018 
Ileoanal pouch microbiota
 19 January 2018 
Predicting the risk of early surgery in Crohn’s
 19 January 2018 
Lifestyle intervention vs gastric bypass for obesity and diabetes
 18 January 2018 
Sleeve gastrectomy vs Roux-en-Y gastric bypass
 18 January 2018 
Healthcare costs of liver cancer in the USA
 18 January 2018 
High-risk adenomas at colonoscopy
 17 January 2018 
“Weekend effect” in upper GI hemorrhage
 17 January 2018 
Gut dysbiosis and non-antibiotic prescription medications
 17 January 2018 
Reducing surgical infections in high-outlier colorectal unit
 16 January 2018 
Bundle of care in GI cancer surgery
 16 January 2018 
Anxiety about colonoscopy
 16 January 2018 
Thiopurines and colorectal neoplasia in IBD
 15 January 2018 
Risks of death after liver transplants for liver cancer
 15 January 2018 
Recent advances in hepatocellular carcinoma
 15 January 2018 
Ileostomy output using telemedicine
 12 January 2018 
Surveillance protocols after colorectal cancer resection
 12 January 2018 
Biologic therapy by pregnant women with IBD and infant vaccines
 12 January 2018 
Biologic therapies for IBD in the USA
 11 January 2018 
Genetic risk factors in GERD
 11 January 2018 
Predictor of colorectal adenoma
 11 January 2018 
Ectopic pregnancy in IBD 
 10 January 2018 
Fecal immunochemical tests for colorectal cancer screening
 10 January 2018 
Risk factors for advanced NAFLD
 10 January 2018 
Dyspepsia prevalence with gastroesophageal reflux–type symptoms
 09 January 2018 
Screening intervals for people with family histories of colorectal cancer
 09 January 2018 
Financial impact of colorectal cancer
 09 January 2018 
Current practice and future research in autoimmune hepatitis
 08 January 2018 
Reliability of the IBD index
 08 January 2018 
Improving prognosis in patients with primary sclerosing cholangitis
 08 January 2018 
Aprepitant and nausea with gastroparesis
 05 January 2018 
Autoimmune pancreatitis and IBD
 05 January 2018 
Primary nonresponse to infliximab therapy
 05 January 2018 
Anesthesia assistance in outpatient colonoscopy
 04 January 2018 
Dietary polyphenols in the etiology of IBD
 04 January 2018 
Yoga vs low-FODMAP in IBS
 04 January 2018 
Local esophageal food allergen injections in eosinophilic esophagitis
 03 January 2018 
Critical research gaps in colorectal cancer
 03 January 2018 
Population health management for IBD
 03 January 2018 
GERD in asthma and COPD
 22 December 2017 
Costs of extrahepatic manifestations of Hep C
 22 December 2017 
Cholera vaccine and risk of death in colorectal cancer
 22 December 2017 
Colonoscopy after colorectal cancer resection
 21 December 2017 
Human oral microbiome and pancreatic cancer risk
 21 December 2017 
Health management for IBD
 21 December 2017 
PPI and Alzheimer's disease
 20 December 2017 
Management of abnormal liver blood tests
 20 December 2017 
Incidence of biopsy-verified celiac disease
 20 December 2017 
Osteoporotic fractures in Barrett's esophagus
 19 December 2017 
Alcohol abstinence and alcoholic hepatitis
 19 December 2017 
Family burden of pediatric Crohn's in the USA
 19 December 2017 
Early readmission in IBD patients
 18 December 2017 
Colorectal cancer mortality with low-risk adenomas at colonoscopy
 18 December 2017 
Disease activity indices in celiac disease
 18 December 2017 
Smoking behaviour predicted the risk of surgery in Crohn's

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2018 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us